Flow cytometry analysis revealed that approximately 35.2 ± 2.3% of tumour cells were CD34 and α6-integrin positive, while 31.7 ± 1.9% of the cells were CD34 positive and α6-integrin negative. Here, CD34 is linked to neoplasm.